Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201

NCT00230490 is registered in ClinicalTrials.gov with Bausch Health Americas, Inc. as lead sponsor.

NCT NCT00230490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00230490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201
Lead sponsor
Bausch Health Americas, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2005
Completion date
May 31, 2007
Enrollment
150
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, chronic